Journal of Pharmacological Sciences ( IF 3.5 ) Pub Date : 2020-05-11 , DOI: 10.1016/j.jphs.2020.05.001 Kanako Miyano 1 , Katsuya Ohbuchi 2 , Yuka Sudo 3 , Kouichiro Minami 4 , Toru Yokoyama 4 , Masahiro Yamamoto 2 , Miaki Uzu 1 , Miki Nonaka 1 , Seiji Shiraishi 1 , Hiroaki Murata 5 , Yoshikazu Higami 6 , Yasuhito Uezono 7
Cellular dielectric spectroscopy (CDS) is a novel technology enabling pharmacological evaluation of multiple receptor types with a label-free cell-based assay. We evaluated activities of a family of ligand-gated channels, transient receptor potential vanilloid 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1) channels by an electrical impedance-based biosensor (CellKey™ system) using CDS. Measures of both potency (EC50) and efficacy (Emax) of these agonists with CellKey™ were almost identical to those made using the traditional Ca2+ influx assay in TRPV1- or TRPA1-expressing cells, suggesting that CellKey™ is a simpler and easier means of evaluating TRP activities.
中文翻译:
一种使用细胞介电谱评估瞬时受体电位通道活性的新方法。
细胞介电谱(CDS)是一项新技术,可通过无标记的基于细胞的测定对多种受体类型进行药理学评估。我们通过使用CDS的基于电阻抗的生物传感器(CellKey™系统)评估了配体门控通道,瞬时受体电势香草酸1(TRPV1)和瞬时受体电势锚蛋白1(TRPA1)通道的活性。用CellKey™对这些激动剂的效价(EC 50)和功效(E max)的测量与在表达TRPV1或TRPA1的细胞中使用传统的Ca 2+内流法进行的测量几乎相同,这表明CellKey™更简单评估TRP活动的简便方法。